文献速递传染病防控与疫情报告卫生政策与健康促进

从更多检测到智能检测:数据引导的SARS-CoV-2检测选择,荷兰,2020年5月至9月

From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020.
PubMed 文献 · Euro Surveill · 2022-01-01

该研究评估了五种快速抗原检测(RDT)识别传染性COVID-19病例的能力,并系统记录了RT-PCR检测的周转时间。研究基于病毒RNA浓度与培养结果的逻辑回归模型,计算了RDT检测传染性病例的概率。最敏感的RDT(Abbott和SD Biosensor)可检测出97.30%的传染性个体,而RT-PCR结果仅32.9%在采样当天可获得。

要点

  • 最敏感的RDT(Abbott和SD Biosensor)可检测出97.30%的传染性个体。
  • RapiGEN的RDT仅检测出75.53%的传染性个体。
  • 仅32.9%的RT-PCR结果在采样当天可获得。

核心结论

  • 最敏感的RDT以高灵敏度检测出传染性COVID-19病例,可能通过更快速的隔离和接触者追踪显著改善疫情遏制。

研究设计与样本

  • 使用已知病毒RNA浓度的连续稀释SARS-CoV-2 stock确定RDT的灵敏度。
  • 基于78例随机选择的非住院病例的病毒RNA浓度与匹配培养结果进行逻辑回归,计算给定病毒载量下检测到传染性病毒的概率。
  • 在1,739例确诊非住院COVID-19病例中,计算每种RDT检测传染性病例的概率为诊断时发现的每个病毒RNA载量对应的病毒分离成功预测概率之和。

主要发现

  • 报告前往drive-through检测的患者的 quantification cycle 值和估计RNA载量分布偏向高RNA载量。
  • 最敏感的RDT(Abbott和SD Biosensor)检测出97.30%(范围:88.65-99.77)的传染性个体。
  • Coris BioConcept和GenBody的RDT检测出92.73%(范围:60.30-99.77)的传染性个体。
  • RapiGEN的RDT检测出75.53%(范围:17.55-99.77)的传染性个体。
  • 仅32.9%的RT-PCR结果在采样当天可获得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundSARS-CoV-2 RT-PCR assays are more sensitive than rapid antigen detection assays (RDT) and can detect viral RNA even after an individual is no longer infectious. RDT can reduce the time to test and the results might better correlate with infectiousness.AimWe assessed the ability of five RDT to identify infectious COVID-19 cases and systematically recorded the turnaround time of RT-PCR testing.MethodsSensitivity of RDT was determined using a serially diluted SARS-CoV-2 stock with known viral RNA concentration. The probability of detecting infectious virus at a given viral load was calculated using logistic regression of viral RNA concentration and matched culture results of 78 specimens from randomly selected non-hospitalised cases. The probability of each RDT to detect infectious cases was calculated as the sum of the projected probabilities for viral isolation success for every viral RNA load found at the time of diagnosis in 1,739 confirmed non-hospitalised COVID-19 cases.ResultsThe distribution of quantification cycle values and estimated RNA loads for patients reporting to drive-through testing was skewed to high RNA loads. With the most sensitive RDT (Abbott and SD Biosensor), 97.30% (range: 88.65-99.77) of infectious individuals would be detected. This decreased to 92.73% (range: 60.30-99.77) for Coris BioConcept and GenBody, and 75.53% (range: 17.55-99.77) for RapiGEN. Only 32.9% of RT-PCR results were available on the same day as specimen collection.ConclusionThe most sensitive RDT detected infectious COVID-19 cases with high sensitivity and may considerably improve containment through more rapid isolation and contact tracing.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. van Beek J, Igloi Z, Boelsums T, et al. From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020. Euro Surveill. 2022. PMID: 35209972. doi:10.2807/1560-7917.ES.2022.27.8.2100702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。